Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
Not recruitingEUCTR 2018-000821-29
A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-lab...
This historical record does not confirm current site availability.
Historical research recordMultiple countriesADHD
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Leuven, Belgium · Namur, Belgium and 9 more locationsSee all locations and recruitment
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 288
- Sponsor
- Takeda Development Center Americas, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Belgium, Germany, Netherlands, ...
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2018-000821-29
- Official title
Show the full official title
A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-lab...
Recruitment & locations
Not recruitingLeuven, Belgium · Namur, Belgium · Freiburg Im Breisgau, Germany
8 more locations
- Köln, Germany
- Mainz, Germany
- Mannheim, Germany
- Almere, Netherlands
- Madrid, Spain
- Pamplona, Spain
- Sabadell, Spain
- Goteborg, Sweden
Registry details
Original registry record (opens in a new tab)Current country statuses
- Belgium — Ended
- Germany — Ended
- Netherlands — Ended
- Spain — Ended
- Sweden — Ended
Historical country statuses
- Austria — Prematurely Ended
- Belgium — Trial now transitioned
- Germany — Trial now transitioned
- Spain — Completed
- United Kingdom — GB - no longer in EU/EEA
- Netherlands — Trial now transitioned
- Portugal — Prematurely Ended
- Sweden — Trial now transitioned
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Takeda Development Center Americas, Inc.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingEUCTR 2010-018579-12
A Phase 3, Randomised, Double-blind, Multicentre, Parallel-group, Placebo- and Active-reference, Dose-optimisation Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children...
France, United Kingdom, Austria, + 7 others
Not recruitingEUCTR 2011-005452-34
A Phase 4, Randomised, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 Compared with OROS-MPH with a Placebo Referance Arm, ...
Germany, Hungary, Italy, + 1 other
Not recruitingISRCTN47247160
A controlled study into the effects of food on the behaviour of young children with attention-deficit hyperactivity disorder
Netherlands